Literature DB >> 17393949

Why blacks do not take part in HIV vaccine trials.

Demetrius L Moutsiakis1, P Nancy Chin.   

Abstract

BACKGROUND: AIDS is still a major cause of death. To combat this disease, researchers are developing a vaccine. Although blacks account for most new infections in the United States, they account for a low percent of experimental vaccine recipients. This study, conducted in a mid-sized U.S. city where vaccine trials are held, seeks to learn why.
METHODS: We conducted 11 in-depth ethnographic interviews. Two groups were targeted: blacks who had not participated in HIV vaccine trials and blacks who had.
RESULTS: Overall, three major causes of nonparticipation were identified: misinformation, fear/mistrust and stigma. Factors that favored participation included having close friends with HIV and being homosexual.
CONCLUSIONS: HIV is considered by many blacks to be a gay, white disease. Steps to increase participation must include efforts to destigmatize the condition and disseminate accurate information. Efforts to address historical causes of mistrust through "education" alone are insufficient. Trust needs to be earned through long-term relationships with black communities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393949      PMCID: PMC2569631     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  13 in total

1.  Distrust, race, and research.

Authors:  Giselle Corbie-Smith; Stephen B Thomas; Diane Marie M St George
Journal:  Arch Intern Med       Date:  2002-11-25

2.  Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group.

Authors:  J Ward; G Brenneman; G W Letson; W L Heyward
Journal:  N Engl J Med       Date:  1990-11-15       Impact factor: 91.245

3.  Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group.

Authors:  M C Keefer; M Wolff; G J Gorse; B S Graham; L Corey; M L Clements-Mann; N Verani-Ketter; S Erb; C M Smith; R B Belshe; L J Wagner; M J McElrath; D H Schwartz; P Fast
Journal:  AIDS Res Hum Retroviruses       Date:  1997-09-20       Impact factor: 2.205

Review 4.  The immune system in vertical HIV infection: the immune response and disease progression.

Authors:  M E Paul
Journal:  AIDS Res Hum Retroviruses       Date:  1997-01-01       Impact factor: 2.205

5.  Prevention of Haemophilus influenzae type b infections in Apache and Navajo children.

Authors:  M Santosham; B Rivin; M Wolff; R Reid; W Newcomer; G W Letson; J Almeido-Hill; C Thompson; G R Siber
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

6.  A magic bullet against AIDS?

Authors:  S D Pinkerton; P R Abramson
Journal:  Science       Date:  1993-10-08       Impact factor: 47.728

7.  A legacy of distrust: African Americans and medical research.

Authors:  V N Gamble
Journal:  Am J Prev Med       Date:  1993 Nov-Dec       Impact factor: 5.043

Review 8.  Under the shadow of Tuskegee: African Americans and health care.

Authors:  V N Gamble
Journal:  Am J Public Health       Date:  1997-11       Impact factor: 9.308

9.  Participation in research and access to experimental treatments by HIV-infected patients.

Authors:  Allen L Gifford; William E Cunningham; Kevin C Heslin; Ron M Andersen; Terry Nakazono; Dale K Lieu; Martin F Shapiro; Samuel A Bozzette
Journal:  N Engl J Med       Date:  2002-05-02       Impact factor: 91.245

10.  Effects of human growth hormone in men over 60 years old.

Authors:  D Rudman; A G Feller; H S Nagraj; G A Gergans; P Y Lalitha; A F Goldberg; R A Schlenker; L Cohn; I W Rudman; D E Mattson
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

View more
  26 in total

1.  Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?

Authors:  Paula M Frew; Matthew Archibald; Nina Martinez; Carlos del Rio; Mark J Mulligan
Journal:  Challenge (Atlanta Ga)       Date:  2007

2.  Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.

Authors:  Edith A M Tarimo; Anna Thorson; Thecla W Kohi; Joachim Mwami; Muhammad Bakari; Eric Sandström; Asli Kulane
Journal:  BMC Public Health       Date:  2010-05-28       Impact factor: 3.295

3.  Curriculum development to increase minority research literacy for HIV prevention research: a CBPR approach.

Authors:  Malika Roman Isler; Andre L Brown; Natalie Eley; Allison Mathews; Kendra Batten; Randy Rogers; Noah Powell; Caressa White; Rosalee Underwood; Kathleen M MacQueen
Journal:  Prog Community Health Partnersh       Date:  2014

Review 4.  Experiences in recruiting volunteers through community based initiatives in phase-1 vaccine trials in India.

Authors:  Seema Sahay; Makesh Kumar; Aylur K Srikrishnan; Vadakkuppatu Ramanathan; Sanjay Mehendale
Journal:  Hum Vaccin Immunother       Date:  2013-10-18       Impact factor: 3.452

5.  Evaluation of a social marketing campaign to increase awareness of immunizations for urban low-income children.

Authors:  Emmanuel M Ngui; Chelsea Hamilton; Melodee Nugent; Pippa Simpson; Earnestine Willis
Journal:  WMJ       Date:  2015-02

6.  A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016.

Authors:  Katherine Foy Huamani; Barbara Metch; Gail Broder; Michele Andrasik
Journal:  Public Health Rep       Date:  2018-12-05       Impact factor: 2.792

7.  Bridging the divide: HIV prevention research and Black men who have sex with men.

Authors:  Michele Peake Andrasik; Christian Chandler; Borris Powell; Damon Humes; Steven Wakefield; Katharine Kripke; Daniel Eckstein
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

8.  Long-chain peer referral to recruit black MSM and black transgender women for an HIV vaccine efficacy trial.

Authors:  Angela Coombs; Willi McFarland; Theresa Ick; Vincent Fuqua; Susan P Buchbinder; Jonathan D Fuchs
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

9.  Factors influencing HIV vaccine community engagement in the urban South.

Authors:  Paula M Frew; Carlos del Rio; Sarah Clifton; Matthew Archibald; Joseph T Hormes; Mark J Mulligan
Journal:  J Community Health       Date:  2008-08

10.  The effect of participant nonresponse on HIV prevalence estimates in a population-based survey in two informal settlements in Nairobi city.

Authors:  Abdhalah K Ziraba; Nyovani J Madise; Mwau Matilu; Eliya Zulu; John Kebaso; Samoel Khamadi; Vincent Okoth; Alex C Ezeh
Journal:  Popul Health Metr       Date:  2010-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.